Edson Guimaraes Lo Turco

Title: Edson Guimaraes Lo Turco: Innovator in Breast Cancer Biomarkers

Introduction

Edson Guimaraes Lo Turco is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of breast cancer. With a total of 2 patents, his work focuses on developing metabolic biomarker sets that enhance the accuracy of breast cancer screening and diagnosis.

Latest Patents

Lo Turco's latest patents revolve around innovative biomarkers for assessing breast cancer. One of his inventions relates to a metabolic biomarker set designed for use in screening and diagnosing breast cancer in mammalian subjects. This set includes specific amino acids such as glutamine, glutamate, and serine, along with lipids. Additionally, his work addresses the prediction of therapeutic responses to neoadjuvant chemotherapy for breast cancer. The method he developed involves obtaining a biological sample, preferably blood, and measuring the amounts and ratios of metabolites. This approach allows for a more reliable assessment of breast cancer.

Career Highlights

Throughout his career, Edson Guimaraes Lo Turco has worked with various companies, including Metabolomycs, Inc. and Biocrates Life Sciences AG. His experience in these organizations has contributed to his expertise in metabolic analysis and biomarker development.

Collaborations

Lo Turco has collaborated with notable professionals in his field, including Ismael Dale Cotrim Guerreiro Da Silva and Therese Koal. These collaborations have further enriched his research and innovations in breast cancer diagnostics.

Conclusion

Edson Guimaraes Lo Turco stands out as an influential inventor in the realm of breast cancer biomarkers. His innovative patents and collaborations reflect his commitment to improving cancer diagnostics and patient outcomes.